Peripheral neuropathy and statins

Prescrire International

Volumn 16, Issue 92, 2007, Pages 247-248

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ARTICLE; AUSTRALIA; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG MARKETING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; HIGH RISK PATIENT; HUMAN; HYPERLIPIDEMIA; INCIDENCE; KIDNEY FAILURE; MUSCLE INJURY; MUSCLE STRENGTH; NEUROPATHY; OUTCOME ASSESSMENT; PARESTHESIA; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; POPULATION BASED CASE CONTROL STUDY; PROSPECTIVE STUDY; REFLEX DISORDER; RHABDOMYOLYSIS; RISK ASSESSMENT; RISK FACTOR; SENSORIMOTOR NEUROPATHY; SENSORY DYSFUNCTION; SIDE EFFECT; TREATMENT DURATION;

ANTICHOLESTEREMIC AGENTS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 36749063124     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Prescrire Rédaction "2-6 Patients ayant une hyperlipidémie" Rev Prescrire 2006; 26 (278 suppl. interactions médicamenteuses): 32.
2. Prescrire Rédaction "Choix d'une statine. Pravastatine et simvastatine sont mieux éprouvées que l'atorvastatine" Rev Prescrire 2006; 26 (276): 692-695.
3. Prescrire Editorial Staff "Statins: muscular adverse effects" Prescrire Int 2003; 12 (63): 21.
4. Prescrire Editorial Staff "Statins: peripheral neuropathy" Prescrire Int 2000; 9 (48): 115.
5. Backes JM and Howard PA "Association of HMG-CoA reductase inhibitors with neuropathy" Ann Pharmacother 2003; 37: 274-278.
6. Adverse Drug Reaction Advisory Committee "Statins and peripheral neuropathy" Austr Adv Drug Reactions Bull 2005; 24 (2): 6.
7. de Langen JJ and van Puijenbroek EP "HMG-CoA-reductase inhibitors and neuropathy: reports to the Netherlands pharmacovigilance centre" The Netherlands Journal of Medicine 2006; 64 (9): 334-338.
8. Gaist D et al. "Statins and risk of polyneuropathy. A case-control study" Neurology 2002; 58: 1333-1337.
9. Anderson JL et al. "Do statins increase the risk of idiopathic polyneuropathy?" Am J Cardiol 2005; 95: 1097-1099.
10. Gaist D et al. "Are users of lipid-lowering drugs at increased risk of peripheral neuropathy?" Eur J Clin Pharmacol 2001; 56: 931-933.
11. Chong PH et al. "Statin-associated peripheral neuropathy: review of the literature" Pharmacotherapy 2004; 24 (9): 1194-1203.
12. Heart Protection Study Collaborative Group "Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions" Lancet 2004; 363: 757-767.
13. Prescrire Editorial Staff "Statins: new data in secondary prevention and diabetes" Prescrire Int 2003; 12 (66): 143-148.